search
Back to results

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions (Diabrasport2)

Primary Purpose

Diabetes Mellitus, Type I, Adjustment of Basal Insulin Flow Rate During Physical Activity, Adjustment of Prandial Insulin in Case of Physical Activity

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Usual algorithm
Diabrasport algorithm
Rest
Holter Glycemic Ipro2, Medtronic
Sponsored by
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Diabetes Mellitus, Type I

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient aged over 18 years
  • Patient with type 1 diabetes for at least 1 year
  • Patient receiving insulin pump under basal-prandial regimen for at least 3 months
  • Patient practicing functional insulin therapy, or using a fixed plane defined food
  • Patients with a stable basal rate for at least 1 week
  • Patient practicing regular physical activity and reproducible identically
  • Patient with HbA1c older than 3 months between 6.5% and 9.5% (HbA1c ≤ 6.5% ≤ 9.5%)
  • Patients with BMI ≤ 35
  • Patient who agreed to participate in the study and who signed an informed consent
  • Patient not participating in another protocol
  • Patient covered by social security

Exclusion Criteria:

  • Patients with a history of severe hypoglycemia without accidental cause in the 6 months preceding the entry in the protocol
  • Patient not receiving its hypoglycaemia below the threshold of 0.5 g / L
  • Patient with perforating foot ulcer or a known history of heart disease or obliterative arteriopathy of the lower limbs, or a history of cerebrovascular accident, or ongoing proliferative retinopathy or renal failure
  • Patient with poorly controlled hypertension
  • Pregnant woman
  • Patients deprived of liberty by judicial or administrative decision, patients placed under legal guardianship

Sites / Locations

  • Hôpital Universitaire
  • Hôpital Henri Duffaut
  • Hôpital Jean Minjoz
  • Hôpital Universitaire
  • Centre Hospitalier Sud-Francilien
  • Centre Hospitalier Louis Pasteur
  • Centre Hospitalier
  • Hôpital Universitaire
  • Fondation Hôtel Dieu du Creusot
  • Centre Hospitalier Régional Universitaire
  • Centre Hospitalier Universitaire
  • Hôpital de la Conception
  • Centre Hospitalier Universitaire
  • Centre Hospitalier
  • Centre Hospitalier Régional Universitaire
  • Hôpital Jean Bernard

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Diabrasport then Rest

Rest then Diabrasport

Arm Description

Between each period, the patient should respect a wash-out period of at least one week, during which they will be asked not to practice physical activity.

Between each period, the patient should respect a wash-out period of at least one week, during which they will be asked not to practice physical activity.

Outcomes

Primary Outcome Measures

the number of hypoglycemic events, defined by any threshold crossing 60 mg / dL (3.33mmol / L), measured in the interstitial glucose sensor continuously over a period of 24h
percentage of time spent over 24 hours in the euglycemic range [70; 180] mg / dL ([3.89, 10] mmol / L)
percentage of time spent over 24 hours in hyperglycemia (> 180 mg / dL) (> 10 mmol / L)

Secondary Outcome Measures

Number of hypoglycemic events, defined by any threshold crossing 70 mg / dL (3.9 mml / L), and <54 mg / dL (3 mmol / l) measured by interstitial continuous glucose sensors
Number of hyperglycemic events, defined by any crossing of the threshold of 180 mg / dL (10 mml / L), measured by continuous interstitial glucose sensors.
Metabolic goals analysis:
percentage of time spent in the intervals [70; 180] and [80; 140] mg / dL, [3.89; 10] and [4.44; 7.78] mmol / L percentage of time passes hypoglycemia (<60mg / dL) (<3.33 mmol / L) percentage of time spent in hypoglycemia (<54mg / dL) (<3 mmol / L) percentage of time spent in hypoglycemia (<70mg / dL) (<3.89 mmol / L) percentage of time spent <80 mg / dL; (<4.44 mmol / L) percentage of time spent in hyperglycemia (> 180 mg / dL) (> 10 mmol / L) percentage of time spent> 140 mg / dL (> 7.78 mmol / L)
Nadirs analysis of blood glucose during the night (value reached)
Nadirs analysis of blood glucose during the night (time to onset)
Analysis of quantities of glucose administration consumed during and at the waning of physical activity
Comparison of average values of continuous glucose measurements according to the period (DIABRASPORT, rest and Baseline) and at different times of the day and night.
Analysis by subgroups, depending on the type of physical activity and its duration, a link between a typology of physical activity or patients, and the number of hypoglycemia events during or waning of physical activity
Analysis of evaluation questionnaires intensity PA (Borg) and quality of life (EVA)
Comparison between number of hypoglycemic events predicted by the prediction function "DIABRASPORT" and number of hypoglycemic events actually occurred.

Full Information

First Posted
August 6, 2015
Last Updated
April 6, 2021
Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
search

1. Study Identification

Unique Protocol Identification Number
NCT02521675
Brief Title
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions
Acronym
Diabrasport2
Official Title
Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
January 2016 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
There is no specific recommendations on the adjustments of the insulin treatment in the event of physical activity (PA) in T1D patients treated on insulin pump therapy. Patients often prefer additional carbohydrates intake rather than the reduction of their insulin doses because of the lack of specific algorithms. The DIABRASPORT 2 study aims to demonstrate that using algorithms DIABRASPORT, during a week of physical activity (PA), the incidence of hypoglycaemia is not different from that obtained during a week of rest without physical activity. It is a multi-center European, controlled, randomized, cross-over, study, in 100 T1D patients practicing an occasional AP. 25 centers involved in this study. After agreeing to participate in the study, patients will read the information leaflet, ask questions to the investigator physician and they will date and sign the consent form. The investigator physician will do the same. They will be then drawn randomly via the electronic CRF (eCRF) to determine the order in which they will realize the rest vs DIABRASPORT sessions. The study will take place in 5 weeks: During the weeks Baseline and Diabrasport, patients will have to make 3 physical activity of 30 to 60 minutes separated by at least 24 hours: moderate activity 3 hours after lunch intense activity 3 hours after lunch activity moderate 90 min after lunch They will use their usual algorithms (Cho intake or adjustment of the dose of insulin) during the week Baseline and they will use the Diabrasport algorithm during the week Diabrasport. Patients will be equipped with a holter Glycemic iPro2, Medtronic, whose data are hidden. During the week of rest, patients should do no physical activity during the week. They will be equipped with the Glycemic holter. Patients will have to fill a food survey the days they practice PA. Between each period, the patient must respect a period of wash-out for one week at least, during which he will be asked to not practice physical activity. Validation of algorithms simple, easy to implement, adaptable by patients, could help to improve balance metabolic and practice of sport among the T1D.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type I, Adjustment of Basal Insulin Flow Rate During Physical Activity, Adjustment of Prandial Insulin in Case of Physical Activity

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diabrasport then Rest
Arm Type
Other
Arm Description
Between each period, the patient should respect a wash-out period of at least one week, during which they will be asked not to practice physical activity.
Arm Title
Rest then Diabrasport
Arm Type
Other
Arm Description
Between each period, the patient should respect a wash-out period of at least one week, during which they will be asked not to practice physical activity.
Intervention Type
Behavioral
Intervention Name(s)
Usual algorithm
Intervention Description
The patient will be fitted with a CGMS (continuous glucose monitoring system) (data not shown) and it will be given the booklet to collect events + food survey The patient goes home and he must perform 3 physical activities during the week (30-60 minutes) using its usual algorithms (glucose administration or adaptation of the BR), in the afternoon, and spacing them at least 24 hours : Moderate activity 3 hours after lunch Intense activity 3 hours after lunch Moderate activity 90 min after lunch These activities should not exceed 1 hour in wherever possible
Intervention Type
Behavioral
Intervention Name(s)
Diabrasport algorithm
Intervention Description
The patient will be fitted with a CGMS (data not shown) and it will be given the booklet to collect events + food survey The patient goes home and he must perform 3 physical activities during the week (identical to those carried out during the week "test algorithms usual" and during comparable periods) using DIABRASPORT algorithms, the afternoon and in the spacing at least 24 hours: Moderate activity 3 hours after lunch Intense activity 3 hours after lunch Moderate activity 90min after lunch These activities shall not exceed one hour
Intervention Type
Behavioral
Intervention Name(s)
Rest
Intervention Description
The patient will be fitted with a CGMS (data not shown) and it will be given the booklet to collect events + food survey. The patient goes home and he will not perform any physical activity during the week
Intervention Type
Device
Intervention Name(s)
Holter Glycemic Ipro2, Medtronic
Primary Outcome Measure Information:
Title
the number of hypoglycemic events, defined by any threshold crossing 60 mg / dL (3.33mmol / L), measured in the interstitial glucose sensor continuously over a period of 24h
Time Frame
24h
Title
percentage of time spent over 24 hours in the euglycemic range [70; 180] mg / dL ([3.89, 10] mmol / L)
Time Frame
24h
Title
percentage of time spent over 24 hours in hyperglycemia (> 180 mg / dL) (> 10 mmol / L)
Time Frame
24h
Secondary Outcome Measure Information:
Title
Number of hypoglycemic events, defined by any threshold crossing 70 mg / dL (3.9 mml / L), and <54 mg / dL (3 mmol / l) measured by interstitial continuous glucose sensors
Time Frame
1 week
Title
Number of hyperglycemic events, defined by any crossing of the threshold of 180 mg / dL (10 mml / L), measured by continuous interstitial glucose sensors.
Time Frame
1 week
Title
Metabolic goals analysis:
Description
percentage of time spent in the intervals [70; 180] and [80; 140] mg / dL, [3.89; 10] and [4.44; 7.78] mmol / L percentage of time passes hypoglycemia (<60mg / dL) (<3.33 mmol / L) percentage of time spent in hypoglycemia (<54mg / dL) (<3 mmol / L) percentage of time spent in hypoglycemia (<70mg / dL) (<3.89 mmol / L) percentage of time spent <80 mg / dL; (<4.44 mmol / L) percentage of time spent in hyperglycemia (> 180 mg / dL) (> 10 mmol / L) percentage of time spent> 140 mg / dL (> 7.78 mmol / L)
Time Frame
1 week
Title
Nadirs analysis of blood glucose during the night (value reached)
Time Frame
1 week
Title
Nadirs analysis of blood glucose during the night (time to onset)
Time Frame
1 week
Title
Analysis of quantities of glucose administration consumed during and at the waning of physical activity
Time Frame
1 week
Title
Comparison of average values of continuous glucose measurements according to the period (DIABRASPORT, rest and Baseline) and at different times of the day and night.
Time Frame
1 week
Title
Analysis by subgroups, depending on the type of physical activity and its duration, a link between a typology of physical activity or patients, and the number of hypoglycemia events during or waning of physical activity
Time Frame
1 week
Title
Analysis of evaluation questionnaires intensity PA (Borg) and quality of life (EVA)
Time Frame
1 week
Title
Comparison between number of hypoglycemic events predicted by the prediction function "DIABRASPORT" and number of hypoglycemic events actually occurred.
Time Frame
1 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient aged over 18 years Patient with type 1 diabetes for at least 1 year Patient receiving insulin pump under basal-prandial regimen for at least 3 months Patient practicing functional insulin therapy, or using a fixed plane defined food Patients with a stable basal rate for at least 1 week Patient practicing regular physical activity and reproducible identically Patient with HbA1c older than 3 months between 6.5% and 9.5% (HbA1c ≤ 6.5% ≤ 9.5%) Patients with BMI ≤ 35 Patient who agreed to participate in the study and who signed an informed consent Patient not participating in another protocol Patient covered by social security Exclusion Criteria: Patients with a history of severe hypoglycemia without accidental cause in the 6 months preceding the entry in the protocol Patient not receiving its hypoglycaemia below the threshold of 0.5 g / L Patient with perforating foot ulcer or a known history of heart disease or obliterative arteriopathy of the lower limbs, or a history of cerebrovascular accident, or ongoing proliferative retinopathy or renal failure Patient with poorly controlled hypertension Pregnant woman Patients deprived of liberty by judicial or administrative decision, patients placed under legal guardianship
Facility Information:
Facility Name
Hôpital Universitaire
City
Angers
ZIP/Postal Code
49933
Country
France
Facility Name
Hôpital Henri Duffaut
City
Avignon
ZIP/Postal Code
84902
Country
France
Facility Name
Hôpital Jean Minjoz
City
Besançon
ZIP/Postal Code
25030
Country
France
Facility Name
Hôpital Universitaire
City
Brest
ZIP/Postal Code
29609
Country
France
Facility Name
Centre Hospitalier Sud-Francilien
City
Corbeil-Essonnes
ZIP/Postal Code
91100
Country
France
Facility Name
Centre Hospitalier Louis Pasteur
City
Dole
ZIP/Postal Code
39108
Country
France
Facility Name
Centre Hospitalier
City
Douai
ZIP/Postal Code
59507
Country
France
Facility Name
Hôpital Universitaire
City
Grenoble
ZIP/Postal Code
38043
Country
France
Facility Name
Fondation Hôtel Dieu du Creusot
City
Le Creusot
ZIP/Postal Code
71200
Country
France
Facility Name
Centre Hospitalier Régional Universitaire
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Lyon
ZIP/Postal Code
69310
Country
France
Facility Name
Hôpital de la Conception
City
Marseille
ZIP/Postal Code
13005
Country
France
City
Merignac
ZIP/Postal Code
33700
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Rennes
ZIP/Postal Code
35056
Country
France
Facility Name
Centre Hospitalier
City
Saint Dié des Vosges
ZIP/Postal Code
88187
Country
France
Facility Name
Centre Hospitalier Régional Universitaire
City
Strasbourg
ZIP/Postal Code
67000
Country
France
Facility Name
Hôpital Jean Bernard
City
Valenciennes
ZIP/Postal Code
59322
Country
France

12. IPD Sharing Statement

Learn more about this trial

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions

We'll reach out to this number within 24 hrs